MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
753,619
Share change
+250
Total reported value
$40,023,205
Price per share
$53.11
Number of holders
46
Value change
+$13,287
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q4 2013

As of 31 Dec 2013, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 753,619 shares. The largest 10 holders included JPMORGAN CHASE & CO, MORGAN STANLEY, ABSOLUTE INVESTMENT MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, COLUMBIA CAPITAL LLC, MONTAG A & ASSOCIATES INC, CREDIT SUISSE AG/, Virtu Financial LLC, and McAdams Wright Ragen, Inc.. This page lists 46 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.